OMass Technologies

Description: OMass Therapeutics uses structural mass spectrometry to discover drugs targeting complex proteins, backed by Syncona & Oxford Science Enterprises.

Country: UK

Based in: Oxford

Founded: 2016

Funding Stage: Series A/B

Tags: ['Life Science', 'Pharmaceutical']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.